New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 18, 2013
08:28 EDTCPRXCatalyst Pharmaceutical initiated with a Buy at Aegis
Target $2.50.
News For CPRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 30, 2014
11:18 EDTCPRXCatalyst Pharmaceutical shares undervalued, says H.C. Wainwright
09:10 EDTCPRXOn The Fly: Pre-market Movers
Subscribe for More Information
05:41 EDTCPRXCatalyst Pharmaceutical to host conference call
Conference call to discuss positive top-line results from the Firdapse clinical trial will be held on September 30 at 8:30 am. Webcast Link
September 29, 2014
18:22 EDTCPRXOn The Fly: After Hours Movers
Subscribe for More Information
17:08 EDTCPRXCatalyst Pharmaceutical up 24% after hours following positive Firdapse data
16:05 EDTCPRXCatalyst Pharmaceutical: Results from Phase 3 trial of Firdapse met co-endpoints
Catalyst Pharmaceutical announced positive top-line results from the pivotal Phase 3 clinical trial of Firdapse for the symptomatic treatment of Lambert-Eaton myasthenic syndrome. Both co-primary endpoints, quantitative myasthenia gravis score and subject global impression, demonstrated that Firdapse was significantly superior to placebo, as did a secondary endpoint for the physician's clinical global impression of improvement. This clinical trial was designed as a double blind, randomized, "withdrawal trial" in which all patients were initially treated with Firdapse during a 91 day run-in period followed by treatment with either Firdapse or placebo during a 2 week randomization period. A total of 38 patients completed the 3 month run-in period and subsequent 2 week randomization period. In a trial of this design, the clinically significant findings, when present, are worsening of symptoms in the placebo group.
16:00 EDTCPRXCatalyst Pharmaceutical trading halted, pending news
Subscribe for More Information
09:53 EDTCPRXCatalyst Pharmaceutical management to meet with Roth Capital
Meeting to be held in San Francisco on October 6 hosted by Roth Capital.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use